Using Deep Sequencing Technology to Detect HCV Resistant Variants
A research team from the Netherlands turns to deep sequencing technology to detect hepatitis C virus resistant variants.
HCV Combination Therapy Found Effective in European Patients
The retrospective study included a cohort of patients from six countries across Europe who were diagnosed with HCV and received daclatasvir during the Named Patient Program.
Hepatitis C Genotype 4 Combination Therapy Found to Be Safe and Effective
According to the Belgian researchers, Sofosbuvir in combination with simeprevir with or without ribarivirn was found to be well-tolerated and efficacious.
Treatment Options for HCV Patients with Renal Impairment
A research group from Hokkaido University in Japan found that standard treatment for those with genotype 1 HCV should likely be switched from interferon (INF)-based therapies to INF-free direct-acting antiviral (DAA) therapies.
Is Interferon Therapy Behind Cognitive Decline in HCV Patients?
Felix Kleefeld, of Berlin, Germany, and colleagues examined how eradicating HCV affected the cognition of patients in a study published in Neurology in December 2016.
HCV Treatment Achieves Viral Suppression in Less Than 12 Weeks
Researchers conducted a post hoc analysis to learn whether or not the length of time it took to attain initial viral suppression is related to sustained virologic response (SVR) rates for patients receiving the so-call 3D treatment, with or without ribavirin.
2 Clarke Drive Cranbury, NJ 08512